Barclays’s Frontline FRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-21,800
| Closed | -$142K | – | 4992 |
|
|
2020
Q3 | $142K | Hold |
21,800
| – | – | ﹤0.01% | 4048 |
|
|
2020
Q2 | $152K | Sell |
21,800
-40,500
| -65% | -$344K | ﹤0.01% | 4261 |
|
|
2020
Q1 | $599K | Buy |
62,300
+34,400
| +123% | +$321K | ﹤0.01% | 3436 |
|
|
2019
Q4 | $359K | Buy |
27,900
+24,100
| +634% | +$263K | ﹤0.01% | 4565 |
|
|
2019
Q3 | $35K | Sell |
3,800
-5,300
| -58% | -$42.8K | ﹤0.01% | 6056 |
|
|
2019
Q2 | $73K | Sell |
9,100
-11,000
| -55% | -$87.5K | ﹤0.01% | 5901 |
|
|
2019
Q1 | $130K | Sell |
20,100
-18,900
| -48% | -$112K | ﹤0.01% | 5155 |
|
|
2018
Q4 | $216K | Buy |
39,000
+11,900
| +44% | +$77.7K | ﹤0.01% | 4518 |
|
|
2018
Q3 | $157K | Buy |
27,100
+1,000
| +4% | +$5.28K | ﹤0.01% | 5188 |
|
|
2018
Q2 | $152K | Sell |
26,100
-4,800
| -16% | -$24.2K | ﹤0.01% | 4951 |
|
|
2018
Q1 | $137K | Sell |
30,900
-1,100
| -3% | -$4.92K | ﹤0.01% | 5149 |
|
|
2017
Q4 | $147K | Buy |
32,000
+4,300
| +16% | +$24K | ﹤0.01% | 4938 |
|
|
2017
Q3 | $167K | Buy |
27,700
+18,000
| +186% | +$102K | ﹤0.01% | 4576 |
|
|
2017
Q2 | $56K | Sell |
9,700
-14,200
| -59% | -$87.2K | ﹤0.01% | 5281 |
|
|
2017
Q1 | $161K | Buy |
23,900
+11,100
| +87% | +$77.5K | ﹤0.01% | 4514 |
|
|
2016
Q4 | $91K | Hold |
12,800
| – | – | ﹤0.01% | 4810 |
|
|
2016
Q3 | $92K | Sell |
12,800
-2,600
| -17% | -$20.1K | ﹤0.01% | 4562 |
|
|
2016
Q2 | $121K | Buy |
15,400
+10,500
| +214% | +$86.3K | ﹤0.01% | 4268 |
|
|
2016
Q1 | $39K | Sell |
4,900
-3,520
| -42% | -$34K | ﹤0.01% | 4914 |
|
|
2015
Q4 | $84K | Buy |
8,420
+220
| +3% | +$3.35K | ﹤0.01% | 4516 |
|
|
2015
Q3 | $82K | Buy |
8,200
+2,540
| +45% | +$34.1K | ﹤0.01% | 4732 |
|
|
2015
Q2 | $57K | Buy |
5,660
+2,200
| +64% | +$29.4K | ﹤0.01% | 5065 |
|
|
2015
Q1 | $35K | Sell |
3,460
-1,900
| -35% | -$26.5K | ﹤0.01% | 5514 |
|
|
2014
Q4 | $54K | Sell |
5,360
-1,860
| -26% | -$15.1K | ﹤0.01% | 5654 |
|
|
2014
Q3 | $36K | Sell |
7,220
-9,240
| -56% | -$101K | ﹤0.01% | 6116 |
|
|
2014
Q2 | $165K | Sell |
16,460
-1,360
| -8% | -$20.7K | ﹤0.01% | 4991 |
|
|
2014
Q1 | $267K | Buy |
17,820
+14,960
| +523% | +$311K | ﹤0.01% | 4520 |
|
|
2013
Q4 | $43K | Sell |
2,860
-3,440
| -55% | -$47.3K | ﹤0.01% | 6279 |
|
|
2013
Q3 | $63K | Buy |
6,300
+360
| +6% | +$4.52K | ﹤0.01% | 5929 |
|
|
2013
Q2 | $53K | Buy |
+5,940
| New | +$58.9K | ﹤0.01% | 6262 |
|
Other funds holding FRO
F
VCM
VFT
Barclays's FRO Position: Q1 2026 in Review
Barclays increased its Frontline (FRO) stake by 206% in Q1 2026, buying an estimated $51.9M and bringing the position to 2,527,159 shares worth $88.1M. The position accounts for 0.02% of the portfolio, ranked #533.
Barclays first reported a position in FRO in Q2 2013 and has held it in 51 quarters since. The position peaked at $100M in Q1 2023. 239 funds tracked by Wall St. Rank hold FRO as of Q1 2026.
- Barclays held 2,527,159 shares of Frontline worth $88.1M as of Q1 2026.
- Barclays bought 1,700,816 Frontline shares in Q1 2026, an estimated $51.9M.
- Frontline made up 0.02% of Barclays's portfolio in Q1 2026, its #533 holding.
- Barclays first reported a position in Frontline in Q2 2013 and has held it in 51 quarters since.
- Barclays's Frontline position peaked at $100M in Q1 2023.
- 239 funds tracked by Wall St. Rank held Frontline as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.